Difficulty: Medium
Average Score: 87%
Practice
Which of the following antidepressants would be considered first line treatment for perinatal depression (PND) that occurs during a pregnancy?
Correct answer
B
Rationale
In the context of perinatal depression (PND) occurring during pregnancy, the correct first-line antidepressant treatment choice is Sertraline (option B). Sertraline is considered safe and effective for use during pregnancy, as it has a relatively low risk of adverse effects on both the mother and the developing fetus compared to other antidepressants.
Paroxetine (option A) is generally avoided during pregnancy due to an increased risk of congenital malformations and neonatal complications. Clomipramine (option C) and Venlafaxine (option D) also carry potential risks during pregnancy, including adverse effects on fetal development and potential complications for the mother.
Educationally, it is crucial for healthcare professionals to be aware of the safety profiles of different antidepressants in the context of perinatal depression to make informed treatment decisions that prioritize the well-being of both the mother and the unborn child. Understanding the specific considerations for medication use during pregnancy helps in providing optimal care for pregnant individuals experiencing mental health challenges.
Paroxetine (option A) is generally avoided during pregnancy due to an increased risk of congenital malformations and neonatal complications. Clomipramine (option C) and Venlafaxine (option D) also carry potential risks during pregnancy, including adverse effects on fetal development and potential complications for the mother.
Educationally, it is crucial for healthcare professionals to be aware of the safety profiles of different antidepressants in the context of perinatal depression to make informed treatment decisions that prioritize the well-being of both the mother and the unborn child. Understanding the specific considerations for medication use during pregnancy helps in providing optimal care for pregnant individuals experiencing mental health challenges.